Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02954874 |
|---|---|
| Brief Title: | Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer |
| First Submitted : | November 3, 2016 |
| First Submitted that Met QC Criteria : | November 3, 2016 |
| First Posted : | November 4, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 17, 2021 |
| Last Update Posted : | April 20, 2021 (Estimate) |